Skip to main content

Structure Therapeutics Inc.

For the period ended Sep 30, 2026. Filed Nov 9, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 9, 2026

GPCR$21.41+5.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 6. Exhibits

EXHIBIT INDEX

Exhibit Number​Description of Document​Form​File No.​Exhibit​Filing Date​Filed Herewith
​​​​​​​​​​​​​
3.1​Amended and Restated Memorandum and Articles of Association of the Registrant.​8-K​001-41608​3.1​February 7, 2023​​
​​​​​​​​​​​​​
4.1​Registrant’s Specimen Certificate for Ordinary Shares.​S-1/A​333-269200​4.1​January 30, 2023​​
​​​​​​​​​​​​​
4.2​Form of Deposit Agreement.​S-1/A​333-269200​4.2​January 30, 2023​​
​​​​​​​​​​​​​
4.3​Form of American Depositary Receipt evidencing American Depositary Shares (included in Exhibit 4.2).​S-1/A​333-269200​4.3​January 30, 2023​​
​​​​​​​​​​​​​
10.1+​Offer Letter, by and between Structure Therapeutics USA Inc. and John Berrios, dated July 21, 2026.​​​​​​​​​X
​​​​​​​​​​​​​
31.1​Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.​​​​​​​​​X
​​​​​​​​​​​​​
31.2​Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.​​​​​​​​​X
​​​​​​​​​​​​​
32.1˄​Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.​​​​​​​​​X
​​​​​​​​​​​​​
32.2˄​Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.​​​​​​​​​X
​​​​​​​​​​​​​
101.INS​Inline XBRL Instance Document​​​​​​​​​X
​​​​​​​​​​​​​
101.SCH​Inline XBRL Taxonomy Extension Schema Document​​​​​​​​​X
​​​​​​​​​​​​​
101.CAL​Inline XBRL Taxonomy Extension Calculation Linkbase Document​​​​​​​​​X
​​​​​​​​​​​​​
101.DEF​Inline XBRL Taxonomy Extension Definition Linkbase Document​​​​​​​​​X
​​​​​​​​​​​​​
101.LAB​Inline XBRL Taxonomy Extension Labels Linkbase Document​​​​​​​​​X
​​​​​​​​​​​​​
101.PRE​Inline XBRL Taxonomy Extension Presentation Linkbase Document​​​​​​​​​X
​​​​​​​​​​​​​
104​Cover Page Interactive Data File (embedded within the Inline XBRL document)​​​​​​​​​X
  • Indicates management contract or compensatory plan

˄ The certifications attached as Exhibits 32.1 and 32.2 accompanying this Quarterly Report on Form 10-Q are not deemed filed with the SEC and are not to be incorporated by reference into any filing of the Company under the Securities Act or the Exchange Act whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.